Oragenics Inc. Common Stock — Quarterly Cash Flow (NYSE:OGEN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 3.87 M2.14 M12.71 M10.07 M7.49 M Total liabilities 3.73 M4.27 M2.87 M1.79 M1.31 M Total equity 137.69 K-2.13 M9.83 M8.28 M6.18 M Total liabilities & shareholders' equities 3.87 M2.14 M12.71 M10.07 M7.49 M Total debt ————— Net debt —————

News

Oragenics amends at-the-market sales agreement with Dawson James Securities

Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - American Rebel Holdings (NASDAQ:AREB), Aura Biosciences (NASDAQ:AURA)

Oragenics partners with Receptor.AI to expand brain therapeutics pipeline

Oragenics appoints Natasha Giordano to board of directors

Oragenics advances toward phase IIa trials for concussion treatment

Oragenics partners with Sterling for concussion drug production

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com

Oragenics stock tumbles after announcing $20 million preferred stock offering

Oragenics announces $20 million preferred stock offering

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium

Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested - TipRanks.com

OGEN stock touches 52-week low at $0.12 amid sharp annual decline